Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Breathing Muscle Training Alongside Cardiac Rehab for Heart Failure

Tests breathing muscle training with cardiac rehab in adults with heart failure.

Plain-language title generated from the registry record
Registry title: A Study to Evaluate Breathing Muscle Training in Cardiac Rehab

Key facts

Where
Rochester, United StatesSee the site

Where in United States

  • Mayo Clinic in RochesterRochester, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Mayo Clinic
Trial code
NCT04984473
Record updated
17 July 2026
Original description
The purpose of this study is to understand if breathing muscle training combined with cardiac rehabilitation influences the blood flow and blood pressure response during exercise.Read full original descriptionShow less

Combined Cardiac Rehabilitation and Inspiratory Muscle Training in Heart Failure

The purpose of this study is to understand if breathing muscle training combined with cardiac rehabilitation influences the blood flow and blood pressure response during exercise.

Inclusion: Adult 18 years and older; English speaking; Has a qualifying heart failure indication for center-based cardiac rehabilitation; Adult 18 years and older; English speaking; Absence of pulmonary, cardiovascular, musculoskeletal, neurologic, or orthopedic diseases. Controls will be matched for age and sex.

Exclusion: HF patients who are unable to engage in a regularly structured exercise training program as part of a clinically indicated center-based outpatient cardiac rehabilitation program; Uremia, history of allergy to iodides. Impaired renal function; Diagnosis of liver disease; Creatinine value greater than 1.3 mg/dL (via clinical record within the past 6 months); Participants unable/unwilling to provide informed consent.

ClinicalTrials.gov NCT04984473